Notes in Ankola CV

To Subscribe, use this Key

Status	Last Update	Fields
Published	09/18/2023	Broad types of shock are (4) {{c1::Hypovolemic, distributive, cardiogenic, and obstructive}}
Published	09/18/2023	BP/MVO2/TEMP of hypovolemic shock {{c1::Low BP, low MVO2, cold}}
Published	09/18/2023	BP/MVO2/TEMP of cardiogenic shock {{c1::Low BP, low MVO2, cold}}
Published	09/18/2023	BP/MVO2/TEMP of obstructive shock {{c1::Low BP, low MVO2, cold}}
Published	09/18/2023	BP/MVO2/TEMP of distributive shock {{c1::Low BP (esp DBP), high MVO2, warm}}
Published	09/18/2023	Treatment options of hypovolemic shock {{c1::Fluids, blood}}
Published	09/18/2023	Treatment options of cardiogenic shock {{c1::inotropic agens, (careful) fluid}}
Published	09/18/2023	Treatment options of obstructive shock {{c1::correct underlying obstruction (pericardiocentesis)}}
Published	09/18/2023	Treatment options of distributive shock {{c1::fluids, vasopressors, antibiotics (septic), EPI (anaphylaxis)}}
Published	09/18/2023	Bleeding (hemhorrage) leads to {{c1::hypovolemic}} shock
Published	09/18/2023	{{c2::Thrombomodulin}} and {{c2::Proteins C and S}} {{c1::Slow down::do what? }} coagulation
Published	09/18/2023	Antithrombin III inhibits (6) {{c1::II, X, VII, IX, XI, and XII (2, 10, 7, 9, 11, 12)}}
Published	09/18/2023	Clot retraction = {{c1::wound comes together}}
Published	09/18/2023	Fibrinolysis takes place {{c1::2 days::time}} after injury
Published	09/18/2023	MoA Heparin {{c1::potentiation of antithrombin III}}
Published	09/18/2023	MoA Warfarin {{c1::inhibits vitamin K epoxide reductase}}
Published	09/18/2023	MoA rivaroxaban, apixaba, edoxaban {{c1::Factor Xa inhibitor}}
Published	09/18/2023	MoA dabigatran, bivalirudin {{c1::Direct thrombin {{c1::IIa) inhibitor}}
Status	Last Update	Fields